Skip to main content
. 2022 Dec 8;14(24):6037. doi: 10.3390/cancers14246037

Table 1.

Characteristics of patients treated for bone neoplasms before the pandemic (Group I) and during the COVID-19 pandemic (Group II). SD—Standard deviation; IQR—interquartile range.

Group I (n = 36) Group II (n = 51) p Value
Gender
  • -

    Male

  • -

    Female
17 (47.2%)
19 (52.8%)
27 (52.9%)
24 (47.1%)		 0.599
Age, mean (SD) (years) 40.7 (16.8) 45.6 (18.7) 0.215
Type of bone neoplasm
  • -

    Osteosarcoma

  • -

    Chondrosarcoma

  • -

    Giant Cell Tumor

  • -

    Other malignant neoplasms

  • -

    Other benign neoplasm
8 (22.2%)
11 (30.6%)
6 (16.7%)
4 (11.1%)
7 (19.4%)
13 (25.5%)
16 (31.4%)
6 (11.8%)
12 (23.5%)
4 (7.8%)
0.923
0.878
0.736
0.116
0.102
Localization of the neoplasm
  • -

    Lower Limb

  • -

    Upper Limb

  • -

    Pelvis and/or Sacrum
19 (52.8%)
9 (25.0%)
8 (22.2%)
25 (49.0%)
13 (25.5%)
13 (25.5%)
0.730
0.843
0.923
Diameter of bone lesion
median (IQR) (mm)
  • -

    Malignant lesions

  • -

    Benign lesions
56 (38.8–70)
67 (54–79)
45 (34–50)
75 (47.5–115)
78 (50–120)
60 (41.3–101.3)
0.025
0.237
0.077